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Abstract
Background: World Trade Center (WTC) responders were exposed to mixture of dust, smoke, chemicals and carcino‑
gens. Studies of cancer incidence in this population have reported elevated risks of cancer compared to the general
population. There is a need to supplement current epidemiologic cancer follow-up with a cancer tissue bank in order
to better elucidate a possible connection between each cancer and past WTC exposure. This work describes the
implementation of a tissue bank system for the WTC newly diagnosed cancers, focused on advancing the under‑
standing of the biology of these tumors. This will ultimately impact the modalities of treatment, and the probability of
success and survival of these patients.
Methods: WTC Responders who participated (as employees or volunteers) in the rescue, recovery and cleanup
efforts at the WTC sites have been enrolled at Mount Sinai in the World Trade Center Health Program. Responders with
cancer identified and validated through linkages with New York, New Jersey, Pennsylvania, and Connecticut cancer
registries were eligible to participate in this biobank. Potential participants were contacted through letters, phone
calls, and emails to explain the research study, consent process, and to obtain the location where their cancer proce‑
dure was performed. Pathology departments were contacted to identify and request tissue samples.
Results: All the 866 solid cancer cases confirmed by the Data Center at Mount Sinai have been contacted and
consent was requested for retrieval and storage of the tissue samples from their cancer. Hospitals and doctors’ offices
were then contacted to locate and identify the correct tissue block for each patient. The majority of these cases con‑
sist of archival paraffin blocks from surgical patients treated from 2002 to 2015. At the time of manuscript writing, this
resulted in 280 cancer samples stored in the biobank.
Conclusions: A biobank of cancer tissue from WTC responders has been compiled with 280 specimens in storage to
date. This tissue bank represents an important resource for the scientific community allowing for high impact studies
on environmental exposures and cancer etiology, cancer outcome, and gene-environment interaction in the unique
population of WTC responders.
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Background
Responders to the World Trade Center (WTC) disaster
were exposed to soot, benzene and other volatile organic
compounds from jet fuels, as well as WTC dust and
smoke, which contained asbestos, silica, cement dust,
glass fibers, heavy metals, polycyclic aromatic hydrocarbons, polychlorinated biphenyls, and polychlorinated
dibenzofurans and dioxins from the burning and collapse
of the planes and the towers [1–3]. Immediately following the 9/11 terrorist attack, concerns were raised about
the potential cancer risk among the WTC responders,
due to their exposures to a complex mix of toxic chemicals that included multiple known and suspected human
carcinogens [4–10]. These carcinogens were contained
in a complex mixture that changed in concentration over
time, and are likely to induce both early (DNA damage,
mutation, reduced DNA repair), as well as late events
(cell proliferation, chronic inflammation). They may also
act on cancer risk and progression through other mechanisms such as reduced immunological competence and
epigenetic alterations of gene regulation [11–14]. Furthermore, there may be a long-term increased cancer risk
among WTC responders because of changes in cancerassociated behaviors (e.g., overweight/obesity) [15–18]
as a consequence of their stressful experience during the
disaster [19].
Few studies have investigated cancer incidence in WTC
responders. A 2009 study of multiple myeloma cases
in WTC responders reported a higher than expected
number of cases in responders aged < 45 years old [20].
A 2011 study investigated cancer among 9853 firefighters enrolled in the Fire Deparment of the City of New
York (FDNY) WTC Health Program in the first 7 years
following 9/11 [21], and reported a higher standardized
incidence ratio (SIR) of cancer in exposed compared to
non-exposed firefighters [21].
A follow-up study of 20,984 WTC responders linked
their data to the tumor registries of New York, New Jersey, Connecticut, and Pennsylvania and identified 575
cancer cases diagnosed from 9/12/2001 to 12/31/2008,
302 of which were diagnosed 6 or more months after the
attack [22]. Standardized incidence ratios to compare
cancer by site in responders with that predicted for the
general population adjusted for age, sex, and ethnicity/
race were elevated for all cancer sites combined (SIR 1.15,
95% confidence interval [CI] 1.06–1.25), and for thyroid
cancer, prostate cancer, hematopoietic and lymphoid
cancers and soft tissue cancers [22].
An updated study of cancer incidence through
2011 among WTC Health Registry enrollees reported
increased all-cancer incidence in both rescue and recovery workers (RRW) (SIR 1.11, 95% CI 1.03–1.20) and
non-rescue and recovery workers (SIR: 1.08, 95% CI
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1.02–1.15) [23]. When compared to the New York State
(NYS) population as a reference, RRW have increased
cancer incidence for all-sites (SIR 1.11, 95% CI 1.03–
1.20), as well as prostate, thyroid and melanoma [23]. The
study cautioned on the lack of biological evidence connecting the results to WTC exposure and emphasized
the need for follow-up studies [23]. A separate study of
head and neck cancer patients reporting WTC exposure
at Memorial Sloan Kettering (2002–2017) identified 87
cases over this time period and reported the annual number and proportion of WTC-exposed head and neck cancer patients have steadily increased since 2002 [24].
Taken together, the results of these studies have
prompted the CDC to add several cancers to the list of
WTC-related health conditions [25] and added evidence
to the importance of ongoing studies of the responder
population.
Due to the reported increased cancer incidence, there
is a clear need to supplement current epidemiologic cancer follow-up with a cancer tissue bank in order to better
elucidate a possible connection between each cancer and
past WTC exposure. Biospecimen resources and their
clinical annotations are among some of the most powerful resources fueling translational research. This work
describes the implementation of a tissue bank system for
the WTC newly diagnosed cancers, focused on advancing the understanding of the biology of these tumors.
This will ultimately impact the modalities of treatment,
and the probability of success and survival of these
patients.

Methods
Definition of the cohort

WTC responders who participated (as employees or
volunteers) in the rescue, recovery and cleanup efforts
at the WTC sites have been enrolled at Mount Sinai in
the World Trade Center Health Program (WTCHP),
which is funded under the James Zadroga 9/11 Health
and Compensation Act of 2010, on the basis of eligibility
criteria including type of duties, site location and dates
and hours worked [22]. The full eligibility criteria have
been described previously in the literature [26–28]. The
medical protocol for the monitoring program includes
self-administered physical and mental health questionnaires, as well as a physical examination, laboratory tests,
spirometry and a chest radiograph. Participants undergo
visits every 12–18 months at WTCHP clinical centers for
monitoring [22]. Over 27,000 responders have had at least
one monitoring visit in the WTCHP and have consented
to aggregation of their data. A total of 20,984 responders have consented to have their records used for medical
research. Most of the participants are males (85%), whites
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(59%), with a range of WTC exposure, but roughly onethird experienced significant exposure to dust [22].
Identification of cancer cases

The WTC Data Center identifies cancer cases through
periodic linkages with the cancer registries of New
York, New Jersey, Pennsylvania and Connecticut, which
accounts for 98% of the responder residences at time of
enrollment in the WTCHP [22]. To complete the linkage,
the last name, first name, sex, race/ethnicity, complete
date of birth, address at registration, and Social Security
number when available (37%) of consented responders
enrolled in the WTCHP from 16 July 2002 to 31 December 2008 (n = 20,984) were provided to each cancer
registry [22]. The full matching methodology has been
described in detail elsewhere [22], but only cancer cases
validated by one of these four state cancer registries were
eligible to participate in this biobank.
Patients’ recruitment and consent

Initial letters were sent to potential participants explaining the study and seeking approval to discuss the consent
process, with information provided for participants to

contact the research team with questions (Fig. 1). After
the consent process was discussed, a consent form was
sent to obtain written permission to retrieve patient tissue blocks at the hospital where their cancer was diagnosed and staged. As part of the consenting process
participants were asked which hospital or doctor’s office
performed the procedure (either biopsy or surgery). The
consent document also queried about storage of their
tissue sample for research purposes. If a response to the
initial letter was not received within weeks, phone calls
were made and additional letters were mailed to explain
the consent process and proceed accordingly. Participants
were also contacted through email. Deceased members of
the cohort were identified through letters and phone calls.
In these cases, family member/next of kin was informed
about the study and the need for tissue block retrieval. We
currently have an Institutional Review Board (IRB) modification pending that will allow us to ask the permission
of the next of kin of those who are deceased for sample
retrieval. All participants were mailed a signed photocopy
of the written consent they provided. All progress, including dates of contact and the content of interactions was
logged in a de-identified and password protected file.

BIOBANK – Procedural Flow Chart
866 confirmed
cases

WTCHP
records
Cancer
registry

503 cancer
diagnoses
aer
enrollment
Paent contact and consent

Paents
contacted
about study
(mail, phone)

Consent forms
Sent

Consent form
returned

Re-contact
paents as
necessary

Hospital /
doctor’s office
that performed
cancer procedure
obtained

Provide more
informaon as
necessary

Fig. 1 Flow-chart of tissue identification, preparation and storage
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Tissue procurement and storage

For cases that were not performed at Mount Sinai, relationships were established with the pathology department at the facility where the procedure occurred. Prior
to requesting the sample, the pathology department was
contacted to identify and confirm the existence of the
correct tissue sample of interest. Afterwards, an official
sample request was provided to the hospital/doctor’s
office together with a shipping label and a request for the
patient’s pathology report. The request included instructions about confirming the diagnosis and identifying the
appropriate area of malignancy for sampling. If weeks
passed without receiving a sample, hospitals and doctors’
offices were re-contacted to sort out any obstacles.
Creating a biobank is a challenge as it is not the policy of many institutions to release their formalin-fixed
paraffin-embedded (FFPE) blocks for risk of contamination or the loss of the block. Instead FFPE blocks are
sectioned into thin slices using a microtome and placed
on glass slides. These slides are sent when samples are
requested [29, 30]. Although the specifics of requested
slides can vary, charged slides were preferred as their
chemical coating more strongly adheres to the sample, which is important for biological applications such
as immunohistochemistry (IHC). Requesting charged
slides also provided the most flexibility for future assays
and research projects. Thus the tissue slide specifications
that were requested from each institution were of 4 µm
thickness, unstained and on charged slides. When the
volume of tumor tissue allowed, a 4 µm tissue curl was
also requested. Additionally, for each sample one hematoxylin and eosin (H&E) stained slide was requested; in
the cases where an H&E slide was not provided, one of
the unstained slides was stained in-house.
Material received from the various institutions was deidentified and a random number was assigned to each
tissue block or set of slides received. If necessary, tissue
blocks were processed into tissue slides for storage and
then returned at the request of the providing hospital or
doctor’s office.
Slides were stored in enclosed slide cases in a secure,
dry and cool place away from dust and any direct light.
It is worth noting that tissue microarrays (TMA) were
considered for storage in place of slides but were ultimately decided against. Like tissue slides, TMAs can be
constructed from FFPE material and are produced when
multiple small tissue “cores” are extracted from different tissue blocks and inserted into one single TMA chip
[31]. This cuts down on costs, resources and amount of
tissue being used [32]. While this is advantageous for
many different types of projects, having hundreds of
samples on one TMA block would not have been ideal
for this biobank project. While TMA blocks are usually
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organized according to sample type to reduce the risk
of contamination, WTC cancer samples come from a
diverse range of cancers. Moreover, when requester
research institutions require samples from the biobank
they need only specific samples applicable to their
respective projects (i.e. only lung cancer samples), and
sending the entire TMA to that institution would be a
waste of tissue material. Additionally, since institutions
rarely send tumor blocks, most samples would still have
been cut into slides before being sent to Mount Sinai;
creating TMAs from these slides would’ve increased the
chance for tissue loss and contamination. TMAs are at
similar risk as tissue slides for antigen degradation [32].

Results
Inventory

All the 866 solid cancer cases confirmed by the Data
Center at Mount Sinai have been contacted and consent was requested for retrieval and storage of the tissue
samples from their cancer (Fig. 2). Hospitals and doctors’ offices were then contacted to locate and identify
the correct tissue block for each patient. The majority of
these cases consist of archival paraffin blocks from surgical patients treated from 2002 to 2015. Samples were
collected from 61 institutions. At the time of manuscript
writing, this resulted in 280 cancer samples stored in the
biobank (Table 1). Forty-five patients had records for two
primary cancers, two patients had records of three primary cancers and one patient had records of four.
Establishing the tissue bank as a resource for the science
community

This biobank serves as a resource available to scientists
for etiologic and outcome studies, thus overcoming the
historical limitations of other research tissue banks.
Access to de-identified clinical data is often complex
due to multiple factors including: difficulty of obtaining
appropriate control tissues, misconceptions of regulatory
and proprietary rules governing tissue banking; specifically IRB, consent, honest broker, de-identification and
ownership issues, scarcity of tissues due to lack of cooperation from surgery, pathology, oncology and clinical/
translational/basic science researchers who may compete
for the same resources.
One of the most important aspects of this project is the
availability of the tissue samples to the scientific community, with the purpose of allowing high impact studies on
environmental exposures and cancer etiology, cancer outcome, and gene-environment interaction in the unique
population of WTC responders. We have established a
process for qualified applicants to request available samples for use in research projects, and a mechanism for
tissue utilization by creating two structures, the research
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BIOBANK – Sample Acquision Flow Chart
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Fig. 2 Flow-chart of tissue acquisition
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Table 1 Frequency of cancer types included in the biobank
Cancer type

N (%)

Breast

16 (5.7)

Colo-rectuma

28 (10.0)

Kidney and renal pelvis

25 (8.9)

Melanoma of the skin

27 (9.7)

Lung and bronchus

24 (8.6)

Thyroid

30 (10.7)

Prostate

62 (22.1)

Head and neckb

21 (7.5)

Urinary bladderc

17 (6.1)

Otherd

30 (10.7)

Total

280 (100.0)

a

Includes: ascending colon, anus, appendix, cecum, hepatic flexure, large
intestine, rectosigmoid junction, tubulovillous adenoma, rectum, sigmoid colon,
transverse colon

b

Includes: larynx, lip, nasopharynx, other oral cavity and pharynx, parotid
gland, salivary gland, tongue, tonsil

c

Includes: ureter

d

Includes: bones and joints, brain, cervix uteri, corpus uteri, esophagus, liver,
miscellaneous, thymus, pancreas, small intestine, soft tissue including heart,
stomach, testis

evaluation panel (REP) and the Coordinating Committee
(CC).
Research evaluation panel to guide tissue utilization

The REP consists of the Principle Investigator of the
tissue bank and three other members of the cancer
research community and is responsible for determining the importance of the proposed studies, the areas of
weakness that require improvement, and for developing
recommendations to the CC. The REP review is scientifically rigorous, and a brief written review is requested for
internal documentation and to guide discussions with the
investigators. The REP convenes regularly by telephone
to discuss and approve projects.
Roles of the Utilization Committee

The Utilization Committee (UC) negotiates the balance
between the scientific merit of a proposal as assessed
by the REP and sample availability and sustainability for
future studies. The UC meets in coordination with the
REP and communicates heavily with REP members in
order to discuss disagreements and differences in the priorities for sample allocation.
Roles of the Coordinating Committee

The biobank has a governing CC that includes a member
from the Centers for Disease Control and Prevention/
National Institute for Occupational Safety and Health
(CDC/NIOSH) funding agency, the latter of which acts as a

resource for information about CDC activities and advises
on the acceptability of the CC’s policies to the CDC. The
CDC member also has the unique capability of informing
other scientists about the availability of the tissue bank. The
CC oversees and guides the tissue bank development and
ongoing activities, acts as the governing body of the developing operating policies, and has prepared a Manual of
Operations for establishing uniform procedures to accession, process, and distribute the tissue samples. The CC
determines priorities for application’s final approval based
on the recommendation of the REP; it also publicizes the
availability of this resource to prospective users.
Agreement and utilization

After final approval is granted, the research institution
requiring the samples must provide IRB approval for the
project, and a data-use-agreement between the institution and the biobank must be created. This ensures that
tissue samples are only being used for their specific, and
approved, purpose. Proposals will only receive de-identified tissue and data, ensuring there is no means to link
tissue samples to participants. If two quality research
proposals are received for similar projects, we will look
for commonality to form collaborations between the two
projects, especially if the type and amount of cancer tissue required is limited. Possible limitations of the process
include the lack of availability of sufficient amount or type
of tissue for the proposed research question, and the possible insufficient number of cases for a certain cancer type.
Dissemination

Outreach and advertising of the tissue bank is accomplished through partnership with the WTCHP, CDC, the
scientific community and the relevant stakeholders and
patient advocacy communities. This approach recognizes
that the creation of an effective, sustainable resource is
dependent on the participation, trust, and involvement of
all these key groups. The existence of the tissue bank, as
well as any results generated by using the tissue samples
is communicated to WTC members, as well as participants in other WTC surveillance programs.
The tissue bank is also presented to the wider scientific community through posters at scientific meetings
and articles for publication in the medical literature.
De-identified raw data generated within this project are
made rapidly available to other WTC researchers and the
wider medical and preventive community. In an effort to
reach out to the community, we have established a secure
cloud-based website within the Mount Sinai server
(http://icahn.mssm.edu/research/epidemiology/capabiliti
es/biorepository-wtc) that acts as an information portal
modeled on previously developed websites by our group.
The website includes general information about the type
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of specimens available, procedures and requirements for
obtaining tissue, as well as the electronic forms necessary
for making tissue requests and inquiries. The website also
includes a password-protected file transfer site, where
letters of intent, documentation, publications and other
reports (such as status of applications, etc.) are posted for
review by the REP, UC, and CC.
All scientific abstracts, presentations, and publications resulting from use of the tissue bank, and patents
or products resulting from use of the tissue bank are
recorded in the website. The number of grants submitted
and the number of grants funded are also being tracked
as a measure of success.
In addition, we have dedicated a full page of the Institute for Translational Epidemiology (ITE) printed brochure to the World Trade Center Biobank. The brochure
is currently distributed to major scientific meetings
focusing on cancer and epidemiology, and has served as
a way to inform the scientific community about the tissue
bank.
Evaluation of the relevance and effectiveness of the tissue
bank

Specialized software is used to provide access-log analysis for the website. This software analyzes the log files
created by the web server and provides invaluable information on how users access the website, including statistical information as well as color graphs that show trends
and usage. The software periodically analyzes the data
and generates reports on samples requests, usage, scientific publications deriving from the tissue bank, number
of grants submitted and funded, among others.
Problems encountered and addressed

Initially, there was difficulty in contacting participants
by phone because of disconnected numbers, incorrect
numbers, and participants not answering their phones
or responding to any messages. In some instances, participants had moved or updated their address since their
enrollment in the cohort, which prevented the delivery of consent forms. This resulted in a limited number
of consent forms returned. However participants were
repeatedly contacted multiple times over multiple days
at different portions of the day. Home, mobile, and work
numbers were used to establish contact together with
sending emails to those members of the cohort who
had provided their email address. Participants were also
contacted by phone in conjunction when consent forms
would arrive at their address. This ensured that cases
were reminded of the incoming documents and could ask
any questions before the forms arrived. Potential participants were also contacted to notify them of an incoming
study being mailed to their address.
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For procedures not performed at Mount Sinai, participants had to be contacted to receive the information at
which hospital/office they had their cancer procedure
performed. This provided another hurdle in acquiring samples, but an emphasis was made on assessing
hospital information whenever contact was made with
participants. Requesting samples from outside institutions required locating and establishing contacts with
the appropriate member of the pathology department.
This entailed completing different procedures for different institutions, which took time to grow accustomed to.
In instances where institutions provided tumor blocks
instead of slides, blocks were processed at Mount Sinai
and returned to the institution as soon as possible.
Future directions

The biobank is in the process of updating the current
samples with the cancers that were diagnosed after 2014.
To increase participation, employees that speak languages other than English will be recruited for the project. In the future we will continue to address patient’s
concerns and fears of participating in the biobank to
increase recruitment. We are also working on linking the
tissue bank with the main WTCHP data set containing
clinical, epidemiological and exposure information, both
at the time of inclusion in the WTCHP and during the
regularly performed follow up, and to the blood sample
collected at baseline.
The biobank has also started to standardize and manage a central repository of tissue samples from various
organs from rodents exposed to WTC dust; including 376
rats exposed to WTC dusts via intratracheal inhalation
[33–36] by NYU. Blood serum and plasma, bone marrow, aortic arch, heart, lung, kidney, liver, spleen, tibialis
anterior muscle, and prostate tissue of rodents are stored
at − 20 °C, − 80 °C, or in 10% formalin according to
standard practice. Relevant information from pathology
reports is also centrally stored, along with details of the
exposure amount and duration, and of the experimental
design. The biobank will facilitate translational studies
that will give a comprehensive view of the effect of WTC
exposure on cancer etiology, occurrence and aggressiveness. All studies using the WTC tissue bank would
benefit from confirming their findings in corresponding
tissues from organs of animals experimentally exposed to
WTC dust.
Following current practice, the biobank of new human
and animal tissue will be used as a resource for the scientific community (Fig. 3). The human and animal tissue banks will be managed in conjunction, and will
follow the same process for receiving requests of samples
from qualified applicants for research purposes, and for
ongoing evaluation of the bank’s utilization. Examples
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thyroid cancer tissue from WTC- and non-WTC thyroid
tissues.
An increased risk of prostate cancer was reported in
the WTC responders and recovery workers cohort but
the association with WTC-related exposures remains
unknown. The ITE and the World Trade Center Biobank
at Mount Sinai conducted a proof of principle study of
the feasibility of inflammatory biomarkers of prostate
cancer using DNA and RNA sequencing. The results of
this study will be compared with a parallel study investigating tumor promotion by WTC dust in genetic and
metastatic prostate cancer models conducted in collaboration with the Department of Oncological Sciences at
Mount Sinai.

Fig. 3 Example of studies using both human and animal samples

of questions that can be addressed include: the association between WTC exposure to specific carcinogens and unique biological markers of cancer initiation
and progression; the study of genetic markers in relation to cancer characteristics and aggressiveness; biological differences between cancers in WTC responders
and in their unexposed counterparts, and between cancers developed in recent years versus those developed
immediately after the WTC disaster; and comparison
of the systemic and local response to WTC dust in cancer-prone animal models and in WTC responders with
cancer.
Examples of studies utilizing the tissue bank resource

Of the 280 cancer cases stored in the biobank, 21 are
head/neck cancer cases of the larynx, lip, nasopharynx,
other oral cavity and pharynx, parotid gland, salivary
gland, tongue, and tonsil.
These samples have been implemented in a pilot project to test biomarkers for DNA methylation and HPVgenotyping from WTC exposed and unexposed cases.
This collaboration is between Rutgers, the State University of New Jersey, Moffitt Cancer Center, and the World
Trade Center Biobank at Mount Sinai.
WTC first responders have a significant increase in
risk of developing thyroid cancer. Together with Johns
Hopkins, the ITE and the World Trade Center Biobank
at Mount Sinai are conducting a research project to
investigate if over-diagnosis of malignant thyroid cancer
occurred among WTC responders by using IHC to test
molecular markers of thyroid malignancy in archived

Discussion
This is the first attempt to organize a bank of tissue from
cancer patients diagnosed after the WTC disaster. Efforts
thus far have been concentrated on building the WTCHP
and other WTC surveillance programs, organizing participant follow-up, and reporting on cancer incidence
through linkage with cancer registries. It is only now,
more than 15 years after the attack, that cancer is becoming an important potential health consequence. Since the
time frame after the exposure is becoming etiologically
relevant for cancer, and the aging cohort is entering a
time in life when cancer becomes more frequent, pertinent research can be conducted.
Research has estimated an increased cancer burden
among WTC-exposed FDNY RRW compared to a demographically similar NYC cohort in the period January 1st
2012 to December 31st, 2013 [37]. This analysis projects
an additional 2960 cancer cases (95% CI 2883–3037),
with elevated estimates among white men for prostate
(1437 [95% CI 1383–1495], thyroid (73 [95% CI 60–86]
and melanoma (201 [95% CI 179–223] [37].
Etiologic studies demand the availability of properly
prepared and stored tissues, making the tissue biobank
of WTC samples a necessity for past and incident cancer cases in the future. By law, hospitals and doctors’
offices are only required to keep histopathology slides for
10 years, after which they can be disposed of [29]. Establishing a biobank of these tumor samples ensures that
they will remain available for research over time, as different types of cancers become more prevalent.
This repository has valuable immediate and future use
through ad hoc designed studies. The linkage with exposure data will allow studying the possible association
between WTC exposure and cancer initiation and progression. The inclusion of clinical data allows for studying
genetic markers in relation to cancer characteristics and
aggressiveness, thus addressing the possibility that cancer
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in WTC responders differs from cancer in an unexposed
similar population.
In order to study the effect of WTC-related exposures
on clinical cancer characteristics it is necessary to conduct genomic research studies, studies of gene-environment interaction, as well as DNA methylation studies
[38, 39]. The tissue bank will be able to offer biological
specimens for testing; the results will be analyzed in conjunction with the epidemiologic and clinical information
available from the WTCHP, as well as with the ongoing
exposure study. FFPE tissue is easily utilized for translational research. DNA, RNA and proteins can all be
extracted from FFPE tissue slides [40]. In fact, even after
IHC, slides can be used as a DNA source [41]. This allows
for a variety of research methods to be utilized, including
IHC and in situ hybridization to study the morphology,
DNA ploidy and high-throughput genomic assays, and
RNA expression.
Finally, future studies on the biological material
banked would be able to observe if cancers developed
later on during the follow-up differ biologically from
cancers developed in the immediate aftermath of the
WTC disaster, thus helping to disentangle the role of
the WTC disaster on cancer occurrence.

Conclusions
A biobank of cancer tissue from WTC responders has
been compiled with 280 specimens in storage. This
tissue bank represents an important resource for the
scientific community allowing for high impact studies
on environmental exposures and cancer etiology, cancer outcome, and gene-environment interaction in the
unique population of WTC responders.
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